VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly earnings results on February 12, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per…
VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly earnings results on February 12, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.45, missing the consensus estimate of $-0.39 by $0.06 per share. Revenue came in at $303.0K, beating the estimate of $256.5K.
VistaGen Therapeutics's stock moved following the earnings release. The stock currently trades at $0.45 with a market capitalization of $129.3M.
Current market data
NASDAQ · VTGN
$0.24
Down: -$0.01 · -4.59%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
sec_filing ·
earnings ·
price ·
earnings ·
